+457.9%
CVNA vs BBIO
+136.7%
+321.3%
-99.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -0.1% | -1.5% | -1.6% |
| 7D | -7.3% | -3.2% | -4.1% | -6.2% |
| 30D | -4.6% | -13.6% | +9.0% | +0.1% |
| 3M | +2.0% | +7.2% | -5.3% | -1.2% |
| 6M | +11.7% | +1.5% | +10.3% | +10.0% |
| YTD | -18.1% | -5.3% | -12.8% | -18.5% |
| 1Y | -2.4% | +37.7% | -40.1% | -15.2% |
| 3Y | +580.6% | +153.9% | +426.7% | +355.0% |
| 5Y | +4.9% | +43.9% | -39.0% | -51.2% |
| All | +457.9% | +136.7% | +321.3% | +108.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling